We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
15 Jul 2020 - 19 Jul 2020
Virtual Venue

Bimodal Contrast Agent Advances Medical Imaging

By MedImaging International staff writers
Posted on 19 Aug 2019
Print article
Image: A bimodal contrast agent provides hybrid images (Photo courtesy of Getty Images).
Image: A bimodal contrast agent provides hybrid images (Photo courtesy of Getty Images).
A new study details a two-in-one probe made of a contrast agent for magnetic resonance imaging (MRI) and a dye for photoacoustic imaging (PI).

Developed at the University of Mons (Belgium) and the Center of Microscopy and Molecular Imaging (CMMI; Charleroi, Belgium), the bimodal agent combines the MRI gadolinium agent Gd-PCTA, and an organic fluorophore dye called ZW800-1. A L‐lysine derivative joins the two via conventional protein end connections. The L‐lysine derivative also possesses a third connectivity, which can be of used to add another biovector, such as a peptide that specifically recognizes a biological disorder. This could make the bimodal probe trimodal.

The bimodal probe enhances MRI contrast as strongly as a commercial MRI agent, while at the same time providing a photoacoustic signal similar to the original PAI probe. The probe can thus provide hybrid images with a high anatomical resolution provided by MRI, and precise localization of the contrast agent thanks to PAI. Preliminary relaxometric and photoacoustic characterizations indicate that the bimodal agent fulfills its function. The study was published on June 26, 2019, in the European Journal of Inorganic Chemistry.

“The aim is to improve the image by combining photoacoustic imaging and magnetic resonance imaging by using a bimodal probe,” said Professor Sophie Laurent, PhD, of the University of Mons. “The organic dye enables PAI, thanks to its fluorescence in the near infrared (NIRF), and the gadolinium complex based on PCTA is ideal for MRI with radio-frequency pulses. The combination leads to a precisely localized, high-resolution bimodal image.”

Related Links:
University of Mons
Center of Microscopy and Molecular Imaging

Print article


Copyright © 2000-2020 Globetech Media. All rights reserved.